We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
C4x Discovery Holdings Plc | LSE:C4XD | London | Ordinary Share | GB00BQQ2RV18 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 12.00 | 10.30 | 10.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/4/2022 16:58 | In case anyone missed it, the INDIVIOR update on Phase 1 SAD of Orexin 1 Inhibitor INDV 2000) was published Feb 16 in the Q4 21 results. The report says Phase 1 MAD is on clinical hold at the instruction of the FDA based on "nonclinical findings from another similar development programme not sponsored by Indivior". However, "major progress" made on formulation and chemical development | t0pgrader | |
07/4/2022 20:46 | Licensing news? | t0pgrader | |
15/3/2022 00:02 | Seems to be a little bit of interest today | alloa2003 | |
10/3/2022 16:43 | Down into the close yet again ! | bloomberg2 | |
08/3/2022 16:34 | Anyone about ? | bloomberg2 | |
01/3/2022 08:57 | DaveMac3, This all started with a badly handled share sale a couple of months ago and the shares have never really got going again. Personally from what I hear I dont think they will need a fund raising but things can change. | alloa2003 | |
01/3/2022 08:34 | Chart breaking down a bit, they need a deal or milestone soon or the talk will turn to another fund raise | davemac3 | |
17/2/2022 11:04 | Yes your absolutely right there Ewan.. Can't be long now surly | bloomberg2 | |
17/2/2022 10:42 | They don't report R&D on the results - you need to follow the link to their quarterly R&D report. Just had a look and there's no new news - still having to do additional toxicology study. | ewanwhose | |
16/2/2022 08:33 | Indivior full year results out!! Can't see any updates on our Orexin-Receptor antagonist C4X 3256 !! ? | bloomberg2 | |
15/2/2022 19:04 | Yes - awaiting deal news | t0pgrader | |
15/2/2022 12:52 | Any one here | bloomberg2 | |
03/2/2022 07:41 | RNS: Grant of Options and Directors Dealing | livewireplus | |
28/1/2022 10:22 | Looking good boys | bloomberg2 | |
24/1/2022 18:04 | Savvy investors will start picking up cheap stock now - whoever "managed" this sale over the last week or so doesnt have a clue. They have smashed a share price and set the rumour mill going again. | alloa2003 | |
24/1/2022 16:16 | Did you buy the dippy dip dip ? | bloomberg2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions